Internal Medicine, The University of Texas Rio Grande Valley School of Medicine, Edinburg, Texas, USA
Internal Medicine, The University of Texas Rio Grande Valley School of Medicine, Edinburg, Texas, USA.
BMJ Open Qual. 2024 Mar 1;13(1):e002480. doi: 10.1136/bmjoq-2023-002480.
Inpatient hyperglycaemia is associated with an increase in morbidity and mortality, number of rehospitalisations and length of hospitalisation. Although the advantages of proper glycaemic control in hospitalised patients with diabetes are well established, a variety of barriers limit accomplishment of blood glucose targets. Our primary aim was to decrease the number of glucose values above 180 mg/dL in non-critical care hospitalised patients using an audit and feedback intervention with pharmacy and internal medicine residents. A resident-led multidisciplinary team implemented the quality improvement (QI) project including conception, literature review, educating residents, iterative development of audit and feedback tools and data analysis. The multidisciplinary team met every 5 weeks and undertook three 'plan-do-study-act' cycles over an 8-month intervention period (August 2022 to March 2023) to educate residents on inpatient hyperglycaemia management, develop and implement an audit and feedback process and assess areas for improvement. We performed 1045 audits analysing 16 095 accu-checks on 395 non-duplicated patients. Most audits showed compliance with guidelines. The monthly run-on chart shows per cent of glucose values above 180 mg/dL in our non-ICU hospitalised patients and an overall pre-to-post comparison of 25.1%-23.0% (p value<0.05). The intervention was well accepted by residents evidenced by survey results. We did not meet our primary aim to reduce hyperglycaemia by 30% and this combined with the audits showing mostly compliance with guidelines suggests that prescribing behaviour was not a key driver of inpatient hyperglycaemia in our population. This internal medicine resident and pharmacy interprofessional collaboration with audit and feedback for inpatient hyperglycaemia was feasible, well accepted and had a statistically significant yet small improvement in inpatient hyperglycaemia. The project may be helpful to others wishing to explore inpatient hyperglycaemia, interprofessional QI with pharmacists, resident-led QI and audit and feedback.
住院患者高血糖与发病率和死亡率增加、再住院次数增加和住院时间延长有关。虽然已充分证实住院糖尿病患者适当血糖控制的优势,但各种障碍限制了血糖目标的实现。我们的主要目的是通过对住院非重症监护患者进行审核和反馈干预,减少血糖值超过 180mg/dL 的次数,该干预由药剂师和内科住院医师实施。一个由住院医师领导的多学科团队实施了质量改进(QI)项目,包括构思、文献综述、教育住院医师、迭代开发审核和反馈工具以及数据分析。多学科团队每 5 周开会一次,并在 8 个月的干预期(2022 年 8 月至 2023 年 3 月)内进行了三个“计划-执行-研究-行动”循环,以教育住院医师管理住院患者高血糖、开发和实施审核和反馈流程并评估改进领域。我们进行了 1045 次审核,分析了 395 名非重复患者的 16095 次 accu-check 检查结果。大多数审核结果均符合指南。每月连续图表显示了我们非 ICU 住院患者的血糖值超过 180mg/dL 的百分比,以及 25.1%-23.0%(p 值<0.05)的总体前后比较。调查结果表明,该干预措施得到了住院医师的广泛认可。我们没有达到将高血糖降低 30%的主要目标,再加上审核结果显示大部分都符合指南,这表明在我们的人群中,处方行为并不是导致住院患者高血糖的主要原因。该内科住院医师和药剂师之间的跨专业合作、针对住院患者高血糖的审核和反馈,具有可行性、得到广泛认可,并使住院患者高血糖的情况有了统计学意义上的但很小的改善。该项目可能有助于其他希望探索住院患者高血糖、药剂师参与的跨专业 QI、住院医师主导的 QI 和审核和反馈的人。